Developer docs
API playgroundTry for free, no card

Search company profiles

Biomedix vascular solution

Full company profile

uuid000c2ya

Namestring
Biomedix vascular solution
Legal namestring
Collaborative Care Diagnostics, LLC
Websiteurl
biomedix.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Biomedix, operating through its legal entity Collaborative Care Diagnostics, LLC, is a privately held healthcare technology company headquartered in St. Paul, Minnesota, that has provided front-line diagnostic solutions for vascular disease detection since 2004. The company's core products, PADnet and PADnet Xpress, are non-invasive vascular assessment systems that use air cuff and photoplethysmography (PPG) probe technology to measure Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI), Segmental Pressure values, and Pulse Volume Recording (PVR) waveforms for identifying peripheral artery disease (PAD) and chronic venous insufficiency (CVI). PADnet Xpress, a portable mobile device capable of completing tests in under 2 minutes, received FDA clearance for home use in November 2022 and expanded to Android in December 2024. The company also offers integrated third-party diagnostic modules including BeamMed MiniOmni for osteoporosis screening, IRIS for diabetic retinopathy, NDD Medical Spirometry for COPD, and NeuroMetrix DPNCheck for peripheral neuropathy.

The Biomedix Xchange platform serves as the central cloud-based, HITRUST CSF-certified population health management hub that aggregates diagnostic data from multiple modalities into a single patient encounter, supports bi-directional EMR/CRM integration, and enables SDoH data collection. Biomedix generates revenue through a hybrid model combining one-time device sales (PADnet hardware, integrated third-party diagnostic devices) with what appears to be recurring SaaS subscription revenue from the Biomedix Xchange platform. The company operates exclusively in the United States and sells through enterprise field sales, channel partner SureFit, and direct website inquiry, targeting podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations. The company is led by CEO John Romans, VP of Product Chris Trygstad, and VP of Customer Success and Growth Jesse Moore, and has no disclosed external funding rounds or institutional investor backing.

Short descriptiontext

Biomedix is a privately held healthcare technology company that develops non-invasive PADnet vascular diagnostic devices and the cloud-based Biomedix Xchange population health platform, serving podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSaint Paul, United States
HQ citystring
Saint Paul
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vascular diagnostic devices, peripheral artery disease screening, population health management, point-of-care diagnostics, chronic disease screening
Industry3 codes
PRIMARYHLALAFAL
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAN
RPM Reimbursement, Billing & Program Operations Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code1 code
  • Ambulatory Health Care Services621
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Vascular Diagnostic Devices & Population Health Platform
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Diagnostic Devices
TypeOne Time License
Description

Sale of PADnet vascular assessment systems, PADnet Xpress mobile screening devices, and related diagnostic hardware. Devices are sold to healthcare providers, hospitals, and health systems for point-of-care testing.

biomedix.com
2Biomedix Xchange SaaS Platform
TypeSubscription Recurring
Description

Cloud-based population health management platform that aggregates diagnostic data. Likely operates on subscription model for ongoing platform access, data storage, and support services.

biomedix.com
3Integrated Third-Party Diagnostic Devices
TypeOne Time License
Description

Revenue from integrated diagnostic devices including BeamMed MiniOmni (osteoporosis), IRIS fundus camera (diabetic retinopathy), NDD Medical Spirometers (COPD), and NeuroMetrix DPNCheck (peripheral neuropathy) hosted on the Biomedix technology stack.

biomedix.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations
Pricing details1 tier
1Custom enterprise pricing for healthcare organizations
ModelOtherBilling cadenceMulti-year contract
Notes

Biomedix does not publicly list pricing. The company sells to healthcare providers, hospitals, health systems, and Medicare Advantage organizations through direct sales. Pricing likely varies based on device configuration, number of units, and service agreements.

biomedix.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1PADnet
Description

Flexible and customizable vascular assessment system designed to identify peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through non-invasive physiologic testing.

biomedix.com
+3 more records
Core offering1 text field

Biomedix manufactures and sells non-invasive point-of-care diagnostic devices—primarily the PADnet and PADnet Xpress systems for detecting peripheral artery disease (PAD) and chronic venous insufficiency (CVI)—and operates the Biomedix Xchange cloud-based population health management platform that aggregates diagnostic data from multiple modalities for healthcare providers, hospitals, health systems, and Medicare Advantage Organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Podiatric services reduce hospitalizations related to obesity by 19% and diabetes by 37%
+5 more records
Product overview1 text field

Biomedix offers a portfolio of point-of-care diagnostic devices integrated through the Biomedix Xchange population health management platform. The core products include PADnet and PADnet Xpress for peripheral artery disease (PAD) and chronic venous insufficiency (CVI) testing, along with integrated diagnostic modules including BeamMed MiniOmni for bone density/osteoporosis screening, IRIS for diabetic retinopathy screening, NDD Medical Spirometry for COPD testing, and NeuroMetrix DPNCheck for peripheral neuropathy detection. The Biomedix Xchange platform serves as the central hub that aggregates data from multiple diagnostic modalities, enabling coordinated care and population health analysis across chronic conditions for value-based care organizations.

Product and service4 records
1PADnet
CategoryVascular Diagnostic Device
Description

A flexible and customizable vascular assessment system designed to identify hidden peripheral vascular disease through non-invasive physiologic testing in clinical settings. Uses air cuff and PPG probe technology to record ABI, TBI, segmental pressures, and PVR waveforms; also supports venous refill studies for CVI testing. Sold to healthcare providers, hospitals, and health systems.

2PADnet Xpress
CategoryMobile Diagnostic Device
Description

A portable, mobile PAD screening device designed for population health management with tests performed in under 2 minutes using a single-page user interface and live signal quality feedback. HITRUST-certified with electrical safety testing for home use per 60601-1-11 standards. Available as a mobile app on Apple App Store and Google Play.

3Biomedix Xchange
CategoryPopulation Health Platform
Description

A web-based population health management platform designed to combine results from multiple diagnostic tests onto a single platform. Enables value-based care organizations to coordinate care through an integrated technology stack that identifies multiple chronic conditions and behavioral health information, with bi-directional EMR/CRM integration and SDoH data collection via digital questionnaires.

4BeamMed MiniOmni
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-05
Description

Donation of PADnet 5th generation device, PADnet Xpress, and digital health assessments for integration into educational and clinical training programs. Supports both student clinical training and research in vascular health, positioning NYCPM as a leader in podiatric education.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-03
Description

Research partnership with world-leading cancer center to screen for PAD in cancer patients undergoing surgery. Dr. Yolanda Bryce, MD serves as Principal Investigator. Study uses PADnet technology to discover PAD prevalence in cancer patients and compare outcomes between cancer patients with and without PAD. Research aims to investigate racial disparities in PAD and amputation rates.

3Healthcare Provider EMR/CRM Systems
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-06
Description

Biomedix Xchange offers bi-directional interface for automated integration with customer and stakeholder EMRs, CRMs, and other systems of record. Enables healthcare organizations to aggregate diagnostic data with existing IT infrastructure.

biomedix.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical and educational sponsorship with WesternU College of Podiatric Medicine. Donation of advanced diagnostic technology to enhance education in podiatric medicine, supporting hands-on training with latest medical devices and techniques.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Long-standing channel partnership where SureFit distributes PADnet products through booths at major podiatry and vascular conferences including APMA, AAPPM, Western Foot and Ankle Conference, DERMfoot, and Region Three. SureFit handles regional distribution and promotional activities at trade shows.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Huntleigh Diagnostics (part of Arjo) manufactures non-invasive vascular assessment equipment (Doppler, ABI/TBI systems) used in clinical settings. It directly overlaps with Biomedix's PADnet on vascular diagnostic capability, target clinician base (podiatry/vascular/PCP), and physiologic-test methodology.

TypeDirect peer
Description

Perimed is a Swedish maker of non-invasive vascular and microcirculation diagnostic instruments used to assess peripheral circulation. Its product set and clinical use cases (PAD/peripheral vascular assessment in office-based settings) closely mirror PADnet's value proposition, making it a direct peer.

TypeDirect peer
Description

Itamar Medical (acquired by ZOLL/Asahi Kasei) develops non-invasive peripheral vascular diagnostics (EndoPAT platform) targeting cardiometabolic and cardiovascular risk assessment. It overlaps with Biomedix in point-of-care vascular endpoints sold to cardiology and primary-care clinicians.

TypeBroad incumbent
Description

Welch Allyn (now part of Baxter) produces a broad portfolio of frontline diagnostic devices including vital-sign and vascular assessment tools sold to clinics and hospitals. It overlaps on primary-care point-of-care vascular testing devices (e.g., ABI systems) but operates as a multi-product incumbent rather than a PAD-focused specialist.

TypeEmerging player
Description

NeuroMetrix makes the DPNCheck device for peripheral neuropathy (sural nerve conduction) which is integrated into the Biomedix Xchange platform. It overlaps on the multi-modality chronic-care screening footprint and clinician channels (podiatry, primary care).

TypeEmerging player
Description

Vivify Health (acquired by Optum) offers an RPM and patient-engagement platform used by health plans and value-based-care providers. It competes for the same MAO and value-based-care budgets that Biomedix targets, though its strength is mobile RPM pathways rather than point-of-care diagnostics.

7Health Recovery Solutions (HRS)
TypeEmerging player
Description

HRS provides a connected-health/RPM platform with condition-specific pathways for chronic disease management. It overlaps with Biomedix Xchange on value-based-care chronic-condition workflows and payer/MA procurement channels.

TypeBroad incumbent
Description

Hologic sells bone densitometry (osteoporosis screening) and women's-health diagnostics — directly comparable to Biomedix's MiniOmni-based osteoporosis screening module and the broader women's vascular screening market (e.g., PAD in women, retinopathy). Hologic operates at much greater scale across a broader diagnostic portfolio.

9Atcor Medical (USCOM)
TypeDirect peer
Description

Atcor Medical (now part of USCOM) developed non-invasive cardiovascular diagnostic devices, including central blood pressure and PWA/PVR-style measurements, used in vascular and primary-care assessments. It overlaps directly with PADnet's non-invasive physiologic testing approach.

TypeBroad incumbent
Description

GE HealthCare offers a broad portfolio of non-invasive vascular and population-health imaging/diagnostic solutions (including ABI-capable peripherals and enterprise cardiology platforms). While not focused narrowly on PAD, it covers adjacent diagnostics and integrated data platforms sold into the same hospital and health-system accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biomedix vascular solution

Vascular Diagnostic Devices & Population Health Platformbiomedix.com

Biomedix is a privately held healthcare technology company that develops non-invasive PADnet vascular diagnostic devices and the cloud-based Biomedix Xchange population health platform, serving podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations across the United States.

What Biomedix vascular solution does

Biomedix, operating through its legal entity Collaborative Care Diagnostics, LLC, is a privately held healthcare technology company headquartered in St. Paul, Minnesota, that has provided front-line diagnostic solutions for vascular disease detection since 2004. The company's core products, PADnet and PADnet Xpress, are non-invasive vascular assessment systems that use air cuff and photoplethysmography (PPG) probe technology to measure Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI), Segmental Pressure values, and Pulse Volume Recording (PVR) waveforms for identifying peripheral artery disease (PAD) and chronic venous insufficiency (CVI). PADnet Xpress, a portable mobile device capable of completing tests in under 2 minutes, received FDA clearance for home use in November 2022 and expanded to Android in December 2024. The company also offers integrated third-party diagnostic modules including BeamMed MiniOmni for osteoporosis screening, IRIS for diabetic retinopathy, NDD Medical Spirometry for COPD, and NeuroMetrix DPNCheck for peripheral neuropathy.

The Biomedix Xchange platform serves as the central cloud-based, HITRUST CSF-certified population health management hub that aggregates diagnostic data from multiple modalities into a single patient encounter, supports bi-directional EMR/CRM integration, and enables SDoH data collection. Biomedix generates revenue through a hybrid model combining one-time device sales (PADnet hardware, integrated third-party diagnostic devices) with what appears to be recurring SaaS subscription revenue from the Biomedix Xchange platform. The company operates exclusively in the United States and sells through enterprise field sales, channel partner SureFit, and direct website inquiry, targeting podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations. The company is led by CEO John Romans, VP of Product Chris Trygstad, and VP of Customer Success and Growth Jesse Moore, and has no disclosed external funding rounds or institutional investor backing.

Biomedix vascular solution firmographics

Firmographics
Name
Biomedix vascular solution
Legal name
Collaborative Care Diagnostics, LLC
Website
https://biomedix.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
101–250 employees
Short description
Biomedix is a privately held healthcare technology company that develops non-invasive PADnet vascular diagnostic devices and the cloud-based Biomedix Xchange population health platform, serving podiatrists, hospitals, health systems, Medicare Advantage Organizations, and value-based care organizations across the United States.
Ownership category
akta.pro rank

Biomedix vascular solution industry classification

Industry
Product category
Vascular Diagnostic Devices & Population Health Platform
NAICS
Ambulatory Health Care Services (621)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAFAL
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLACAFAN
RPM Reimbursement, Billing & Program Operations Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Vascular diagnostic devices
  • Peripheral artery disease screening
  • Population health management
  • Point-of-care diagnostics
  • Chronic disease screening

Where Biomedix vascular solution is headquartered

Location

Headquarters

HQ city
Saint Paul
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Biomedix vascular solution business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

  1. Medical Diagnostic Devices: Sale of PADnet vascular assessment systems, PADnet Xpress mobile screening devices, and related diagnostic hardware. Devices are sold to healthcare providers, hospitals, and health systems for point-of-care testing.
  2. Biomedix Xchange SaaS Platform: Cloud-based population health management platform that aggregates diagnostic data. Likely operates on subscription model for ongoing platform access, data storage, and support services.
  3. Integrated Third-Party Diagnostic Devices: Revenue from integrated diagnostic devices including BeamMed MiniOmni (osteoporosis), IRIS fundus camera (diabetic retinopathy), NDD Medical Spirometers (COPD), and NeuroMetrix DPNCheck (peripheral neuropathy) hosted on the Biomedix technology stack.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing for healthcare organizations

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Biomedix vascular solution product offering

Product offering

Core offering

Biomedix manufactures and sells non-invasive point-of-care diagnostic devices—primarily the PADnet and PADnet Xpress systems for detecting peripheral artery disease (PAD) and chronic venous insufficiency (CVI)—and operates the Biomedix Xchange cloud-based population health management platform that aggregates diagnostic data from multiple modalities for healthcare providers, hospitals, health systems, and Medicare Advantage Organizations.

Product overview

Biomedix offers a portfolio of point-of-care diagnostic devices integrated through the Biomedix Xchange population health management platform. The core products include PADnet and PADnet Xpress for peripheral artery disease (PAD) and chronic venous insufficiency (CVI) testing, along with integrated diagnostic modules including BeamMed MiniOmni for bone density/osteoporosis screening, IRIS for diabetic retinopathy screening, NDD Medical Spirometry for COPD testing, and NeuroMetrix DPNCheck for peripheral neuropathy detection. The Biomedix Xchange platform serves as the central hub that aggregates data from multiple diagnostic modalities, enabling coordinated care and population health analysis across chronic conditions for value-based care organizations.

Differentiator

Problem solved

Functional benefit

Brands

  • PADnet: Flexible and customizable vascular assessment system designed to identify peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through non-invasive physiologic testing.
  • PADnet Xpress
  • Biomedix Xchange
  • MiniOmni

Products and services

  • PADnet A flexible and customizable vascular assessment system designed to identify hidden peripheral vascular disease through non-invasive physiologic testing in clinical settings. Uses air cuff and PPG probe technology to record ABI, TBI, segmental pressures, and PVR waveforms; also supports venous refill studies for CVI testing. Sold to healthcare providers, hospitals, and health systems.
  • PADnet Xpress A portable, mobile PAD screening device designed for population health management with tests performed in under 2 minutes using a single-page user interface and live signal quality feedback. HITRUST-certified with electrical safety testing for home use per 60601-1-11 standards. Available as a mobile app on Apple App Store and Google Play.
  • Biomedix Xchange A web-based population health management platform designed to combine results from multiple diagnostic tests onto a single platform. Enables value-based care organizations to coordinate care through an integrated technology stack that identifies multiple chronic conditions and behavioral health information, with bi-directional EMR/CRM integration and SDoH data collection via digital questionnaires.
  • BeamMed MiniOmni

Quantifiable outcome

  • Podiatric services reduce hospitalizations related to obesity by 19% and diabetes by 37%
  • +5 more outcomes

Companies that use Biomedix vascular solution

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Biomedix vascular solution technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Biomedix vascular solution partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • New York College of Podiatric Medicine (NYCPM)coreStrategic or Co-development Partner · 5 December 2024Donation of PADnet 5th generation device, PADnet Xpress, and digital health assessments for integration into educational and clinical training programs. Supports both student clinical training and research in vascular health, positioning NYCPM as a leader in podiatric education.
  • Memorial Sloan Kettering Cancer Center (MSKCC)coreStrategic or Co-development Partner · 3 October 2023Research partnership with world-leading cancer center to screen for PAD in cancer patients undergoing surgery. Dr. Yolanda Bryce, MD serves as Principal Investigator. Study uses PADnet technology to discover PAD prevalence in cancer patients and compare outcomes between cancer patients with and without PAD. Research aims to investigate racial disparities in PAD and amputation rates.
  • Healthcare Provider EMR/CRM SystemscoreTechnology or Integration · 6 October 2022Biomedix Xchange offers bi-directional interface for automated integration with customer and stakeholder EMRs, CRMs, and other systems of record. Enables healthcare organizations to aggregate diagnostic data with existing IT infrastructure.
  • Western University of Health Sciences College of Podiatric MedicinecoreStrategic or Co-development PartnerClinical and educational sponsorship with WesternU College of Podiatric Medicine. Donation of advanced diagnostic technology to enhance education in podiatric medicine, supporting hands-on training with latest medical devices and techniques.
  • SureFitcoreChannel Partner/ Reseller/ DistributorLong-standing channel partnership where SureFit distributes PADnet products through booths at major podiatry and vascular conferences including APMA, AAPPM, Western Foot and Ankle Conference, DERMfoot, and Region Three. SureFit handles regional distribution and promotional activities at trade shows.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Biomedix vascular solution competitors and assessment

Company assessment

Direct peers

  • Huntleigh Diagnostics: Huntleigh Diagnostics (part of Arjo) manufactures non-invasive vascular assessment equipment (Doppler, ABI/TBI systems) used in clinical settings. It directly overlaps with Biomedix's PADnet on vascular diagnostic capability, target clinician base (podiatry/vascular/PCP), and physiologic-test methodology.
  • Perimed: Perimed is a Swedish maker of non-invasive vascular and microcirculation diagnostic instruments used to assess peripheral circulation. Its product set and clinical use cases (PAD/peripheral vascular assessment in office-based settings) closely mirror PADnet's value proposition, making it a direct peer.
  • Itamar Medical: Itamar Medical (acquired by ZOLL/Asahi Kasei) develops non-invasive peripheral vascular diagnostics (EndoPAT platform) targeting cardiometabolic and cardiovascular risk assessment. It overlaps with Biomedix in point-of-care vascular endpoints sold to cardiology and primary-care clinicians.
  • Atcor Medical (USCOM): Atcor Medical (now part of USCOM) developed non-invasive cardiovascular diagnostic devices, including central blood pressure and PWA/PVR-style measurements, used in vascular and primary-care assessments. It overlaps directly with PADnet's non-invasive physiologic testing approach.

Broad incumbents

  • Welch Allyn (Baxter): Welch Allyn (now part of Baxter) produces a broad portfolio of frontline diagnostic devices including vital-sign and vascular assessment tools sold to clinics and hospitals. It overlaps on primary-care point-of-care vascular testing devices (e.g., ABI systems) but operates as a multi-product incumbent rather than a PAD-focused specialist.
  • Hologic: Hologic sells bone densitometry (osteoporosis screening) and women's-health diagnostics — directly comparable to Biomedix's MiniOmni-based osteoporosis screening module and the broader women's vascular screening market (e.g., PAD in women, retinopathy). Hologic operates at much greater scale across a broader diagnostic portfolio.
  • GE HealthCare: GE HealthCare offers a broad portfolio of non-invasive vascular and population-health imaging/diagnostic solutions (including ABI-capable peripherals and enterprise cardiology platforms). While not focused narrowly on PAD, it covers adjacent diagnostics and integrated data platforms sold into the same hospital and health-system accounts.

Emerging players

  • NeuroMetrix: NeuroMetrix makes the DPNCheck device for peripheral neuropathy (sural nerve conduction) which is integrated into the Biomedix Xchange platform. It overlaps on the multi-modality chronic-care screening footprint and clinician channels (podiatry, primary care).
  • Vivify Health (Optum): Vivify Health (acquired by Optum) offers an RPM and patient-engagement platform used by health plans and value-based-care providers. It competes for the same MAO and value-based-care budgets that Biomedix targets, though its strength is mobile RPM pathways rather than point-of-care diagnostics.
  • Health Recovery Solutions (HRS): HRS provides a connected-health/RPM platform with condition-specific pathways for chronic disease management. It overlaps with Biomedix Xchange on value-based-care chronic-condition workflows and payer/MA procurement channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biomedix vascular solution social profiles

Digital presence

Biomedix vascular solution compliance and trust

Trust signal

Compliance2 records

Biomedix vascular solution financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biomedix vascular solution leadership team

Management profile

Number of profiles

Profiles3 records

Biomedix vascular solution funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biomedix vascular solution M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomedix vascular solution

What does Biomedix vascular solution do?

Biomedix manufactures and sells non-invasive point-of-care diagnostic devices—primarily the PADnet and PADnet Xpress systems for detecting peripheral artery disease (PAD) and chronic venous insufficiency (CVI)—and operates the Biomedix Xchange cloud-based population health management platform that aggregates diagnostic data from multiple modalities for healthcare providers, hospitals, health systems, and Medicare Advantage Organizations.

Is Biomedix vascular solution a public or private company?

Biomedix vascular solution is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biomedix vascular solution founded?

Biomedix vascular solution was founded in 2004. It employs 101 to 250 people.

Where is Biomedix vascular solution based?

Biomedix vascular solution is headquartered in Saint Paul, United States, in the North America region.

How does Biomedix vascular solution make money?

Three revenue lines are on record. Medical Diagnostic Devices are the primary driver. The others are biomedix Xchange SaaS Platform and integrated Third-Party Diagnostic Devices.

Who are Biomedix vascular solution's main competitors?

Direct peers on record are Huntleigh Diagnostics, Perimed, Itamar Medical and Atcor Medical (USCOM). Broad incumbents are Welch Allyn (Baxter), Hologic and GE HealthCare. Emerging players are NeuroMetrix, Vivify Health (Optum) and Health Recovery Solutions (HRS).

Does Biomedix vascular solution have an API?

No public API is recorded for Biomedix vascular solution.

What industry is Biomedix vascular solution in?

Biomedix vascular solution's product category is Vascular Diagnostic Devices & Population Health Platform. Its primary akta.pro industry code is HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 621 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals